4//SEC Filing
Bello Akintunde Olatokumbo 4
Accession 0001415889-25-016962
CIK 0001840233other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:34 PM ET
Size
5.4 KB
Accession
0001415889-25-016962
Insider Transaction Report
Form 4
Bello Akintunde Olatokumbo
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-10+62,000→ 62,000 totalExercise: $0.70Exp: 2035-06-09→ Common Stock (62,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 10, 2025 and will vest in three equal installments on June 10, 2026, June 10, 2027 and June 10, 2028, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0002070709
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:34 PM ET
- Size
- 5.4 KB